Giuseppe Cardaci

Randomised phase 2 trial of SIR‐Spheres® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer

Guy van Hazel, Anthony Blackwell, James Anderson et al. · Journal of Surgical Oncology · 2004 · 442 citations

Medicine, Oncology, Radiation Oncology +17

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, Navesh Sharma, Volker Heinemann et al. · The Lancet Oncology · 2017 · 398 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study

Mike Sathekge, Ismaheel O. Lawal, Chandrasekhar Bal et al. · The Lancet Oncology · 2024 · 178 citations

Medicine, Oncology, Urology +17

Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies

Volker Heinemann, Navesh Sharma, Jens Ricke et al. · Clinical Colorectal Cancer · 2018 · 68 citations

Medicine, Oncology, Radiation Oncology +17

Salvage Radiopeptide Therapy of Advanced Castrate-Resistant Prostate Cancer with Lutetium-177-Labeled Prostate-Specific Membrane Antigen: Efficacy and Safety in Routine Practice

Murali Kesavan, J. Harvey Turner, Danielle Meyrick et al. · Cancer Biotherapy and Radiopharmaceuticals · 2018 · 31 citations

Medicine, Oncology, Pharmacotherapy +17